UCB, a global biopharmaceutical company, today announced the start of BE BOLD, a head-to-head Phase 3b study, comparing BIMZELX® (bimekizumab-bkzx), an interleukin (IL)-17A and IL-17F inhibitor, with ...

The global psoriatic arthritis (PsA) treatment market is poised for remarkable expansion, with an anticipated valuation of ...

Juvenile idiopathic arthritis symptoms may only affect certain joints. Some children have systemic reactions, such as rash.

Hip arthritis presents in several forms such as osteoarthritis, rheumatoid arthritis, and avascular necrosis, each with ...

A new hand-held scanner can spot minuscule changes in veins and arteries deep within human tissues, which could provide ...

The newest drugs and treatments for rheumatoid arthritis (RA) include Janus kinase (JAK) inhibitors, a Bruton’s tyrosine kinase (BTK) inhibitor, and neurostimulation, among other treatments.

More than 75% of the cohort started a TNF inhibitor during the selected time frame. For the rest, JAK inhibitors were the ...

A groundbreaking study led by scientists from the University of Colorado has uncovered a potential trigger for rheumatoid ...

Living with Rheumatoid Arthritis can feel like an uphill battle, but new groundbreaking research offers hope for earlier ...

In summary, RA is a complex disease influenced by genetic and environmental factors. Early diagnosis, targeted treatment, and ...

Plaque psoriasis (PsO) and psoriatic arthritis (PsA) are lifelong conditions that can have a significant impact on those ...